1. Home
  2. AURA vs KTWO Comparison

AURA vs KTWO Comparison

Compare AURA & KTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.54

Market Cap

429.2M

Sector

Health Care

ML Signal

HOLD

KTWO

K2 Capital Acquisition Corporation Class A Ordinary Share

N/A

Current Price

$9.88

Market Cap

431.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AURA
KTWO
Founded
2007
2025
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.2M
431.2M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
AURA
KTWO
Price
$6.54
$9.88
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
238.6K
43.3K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.73
$9.84
52 Week High
$7.48
$9.89

Technical Indicators

Market Signals
Indicator
AURA
KTWO
Relative Strength Index (RSI) 57.25 54.39
Support Level $5.83 $9.87
Resistance Level $6.73 $9.89
Average True Range (ATR) 0.41 0.01
MACD -0.00 0.00
Stochastic Oscillator 54.67 100.00

Price Performance

Historical Comparison
AURA
KTWO

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: